Nu Skin Enterprises, Inc.
NUS
$5.77
$0.050.87%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -534.90% | 107.02% | -22,087.24% | -107.32% | 119.71% |
| Total Depreciation and Amortization | -5.03% | -1.60% | -4.52% | -0.79% | 12.68% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 315.15% | -94.57% | 793.83% | 97.23% | -87.92% |
| Change in Net Operating Assets | 490.18% | 33.73% | 87.52% | -264.56% | 1,242.02% |
| Cash from Operations | -17.97% | -38.62% | 1,443.31% | -93.87% | 6.15% |
| Capital Expenditure | -46.38% | -5.82% | 33.86% | 39.75% | -71.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -150.71% | 602.21% | -113.51% | -39.46% | -- |
| Cash from Investing | -108.06% | 23.26% | 7.89% | 39.85% | -29.33% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | 0.39% | -58.07% | -24.01% | -2,447.18% | 86.02% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -11.32% | 11.67% | 96.83% | -950.56% | 98.62% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00% | -0.03% | -0.10% | 84.54% | 1.11% |
| Other Financing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Financing | -51.59% | 0.14% | 9.82% | -57.69% | 47.19% |
| Foreign Exchange rate Adjustments | -227.20% | 445.35% | 61.94% | -232.72% | 241.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,267.32% | -70.12% | 126.92% | -291.38% | 1,115.31% |